Tizon, Baby Girl I .

HRN: 25-50-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/25/2024
08/01/2024
IV
17mg LD; 8mg MD
OD
PSNB
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: